Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.40 per share
-
Shares outstanding
-
23.6M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
107M
-
Shares change
-
+57.9M
-
Total reported value, excl. options
-
$204M
-
Value change
-
+$110M
-
Put/Call ratio
-
0.03
-
Number of buys
-
40
-
Number of sells
-
-26
-
Price
-
$1.90
Significant Holders of Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) as of Q4 2022
87 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share as of Q4 2022.
Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 107M shares
.
Largest 10 shareholders include Syncona Portfolio Ltd (21.3M shares), Blackstone Inc. (20.5M shares), Deep Track Capital, LP (15M shares), ARMISTICE CAPITAL, LLC (10.2M shares), TFG Asset Management GP Ltd (8.3M shares), Nantahala Capital Management, LLC (7.78M shares), Frazier Life Sciences Management, L.P. (3.75M shares), Odey Asset Management Group Ltd (2.5M shares), CITADEL ADVISORS LLC (1.78M shares), and Pendal Group Ltd (1.73M shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.